LITTLE GREEN PHARMA LTD — Proxy Solicitation & Information Statement 2021

Jun 16, 2021

17 June 2021

==> picture [413 x 243] intentionally omitted <==

Dear Shareholders,

Little Green Pharma Ltd - Notice of Extraordinary General Meeting

Little Green Pharma Ltd (ASX: LGP) ( Company ) advises that an extraordinary general meeting of the Company will be held at Suite 2, Level 2, 66 Kings Park Road, West Perth, WA on Monday, 19 July 2021 at 2:00pm (WST) via Zoom webinar ( Meeting ).

The Australian Securities and Investments Commission (ASIC) has adopted a temporary ‘no-action’ position which follows on from the measures granted under the Corporations (Coronavirus Economic Response) Determination (No. 3) 2020 which expired on 21 March 2021.

ASIC’s ‘no action’ policy supports the holding of meetings using appropriate technology and the electronic dispatch of notices of meeting. Accordingly, the Company will not be sending hard copies of the Notice of Extraordinary General Meeting (Notice) to shareholders. Instead, the Notice can be viewed and downloaded from the Company's investor centre website at: https://investor.littlegreenpharma.com/site/investor-centre/extraordinary-general-meeting-19-july-2021

Should you wish to receive a hard copy of the Notice, please contact the Company Secretary on CoSec@lgpharma.com.au or by telephone on +61 8 6280 0050.

Meeting to be held virtually

In accordance with ASIC's temporary ‘no action’ policy, the Meeting will be held virtually with shareholders participating in the Meeting via Zoom webinar. The webinar details are: https://us02web.zoom.us/webinar/register/WN_svURlNSzQhG_Ain5FST5sw

Participating in the Meeting virtually will enable shareholders to view the Meeting live, ask questions and cast votes in real time. Votes will be taken by poll rather than a show of hands.

Participation and voting at the Meeting

If you intend to vote on a poll at the Meeting, you must notify the Company Secretary at CoSec@lgpharma.com.au. Following the Proxy Cut-Off Time (as specified in the Notice), the Company will send you a personalised poll form ( Poll Form ). The Poll Form must be completed and returned to the Company after the poll has been called and prior to the close of polling. During the Meeting, the Chair will notify you how and when you are able to complete and return the Poll Form.

Head Office PO Box 690, West Perth WA 6872 | T + 61 8 6280 0050 | E info@littlegreenpharma.com | littlegreenpharma.com

==> picture [540 x 105] intentionally omitted <==

Voting by Proxy

If you do not wish to vote during the Meeting, you may appoint the Chair as your proxy ahead of the Meeting. A copy of your Proxy Form is enclosed for convenience. Proxy votes may be lodged by no later than 48 hours before the Meeting by any of the below methods:

• in person at Suite 2, Level 2, 66 Kings Park Road, West Perth WA 6005;

• by post to PO Box 690, West Perth WA 6872;

• by post to ComputerShare Investor Services Pty Ltd at GPO Box 242, Melbourne Victoria 3001;

• by scan and email to CoSec@lgpharma.com.au; or

• electronically through the Company Registry’s www.investorvote.com.au website (control number 185283).

Further information

Further information on how to:

• vote and participate in the virtual Meeting; and

• vote by Proxy prior to the Meeting,

is contained in the Notice and on the Company’s investor centre website (see link on page 1 above).

Questions

Alternatively, if you have been nominated as a proxy, or for any enquiries relating to virtual participation in the Meeting or accessing the Company’s investor centre website, please contact the Company Secretary at CoSec@lgpharma.com.au or by telephone on (08) 6280 0050.

The COVID-19 situation is constantly evolving and accordingly we may make alternative arrangements to the way in which the Meeting is held. If this occurs, we will notify any changes by way of announcement on the ASX platform and the Company’s investor centre website. The Notice is an important document and should be read in its entirety. If you are in doubt as to the course of action you should follow, you should consult your financial adviser, lawyer, accountant or other professional adviser.

==> picture [168 x 204] intentionally omitted <==

For and on behalf of the Board.

Yours faithfully

Mr. Michael Lynch-Bell Non-Executive Chairman

LITTLE GREEN PHARMA LTD ABN: 44 615 586 215 Suite 2, Level 2, 66 Kings Park Road, West Perth, 6005, WA www.littlegreenpharma.com.au

Help us be Green

LGP investors are encouraged to go paperless and receive Company communications, notices and reports by email. This will ensure efficient communication during COVID-19 while also helping to reduce our costs and environmental footprint. To easily update your communication preferences, visit: www.computershare.com.au/easyupdate/lgp

Head Office PO Box 690, West Perth WA 6872 | T + 61 8 6280 0050 | E info@littlegreenpharma.com | littlegreenpharma.com2

2